Hostname: page-component-586b7cd67f-rcrh6 Total loading time: 0 Render date: 2024-11-30T18:51:15.090Z Has data issue: false hasContentIssue false
  • English
  • Français

The Department of Neuroscience at the Institute of Psychiatry

Published online by Cambridge University Press:  09 July 2009

Brian Anderton  and
Robert Kerwin
Brian Anderton
Affiliation:
Department of Neuroscience, Institute of Psychiatry, London
Robert Kerwin*
Affiliation:
Department of Neuroscience, Institute of Psychiatry, London
*
1 Address for correspondence: Dr R. Kerwin, Department of Neuroscience, Institute of Psychiatry, De Crespigny Park, London SE5 8AF.
Get access Rights & Permissions [Opens in a new window]

Extract

During the 1988/89 academic year the Department of Neuroscience was formed at the Institute of Psychiatry from the former Departments of Biochemistry and Pharmacology. The University agreed to the establishment of a new Chair of Neuroscience to accompany this academic initiative and to which Professor Brian Anderton was appointed in 1989. In 1989, a new Lecturer in Molecular Biology, Dr John Powell, was appointed as well as a Clinical Senior Lecturer jointly with the Department of Psychiatry, Dr Robert Kerwin; this latter post was a new post under the UFC New Clinical Appointments Scheme. These changes have led to a strengthening of the molecular and cellular neurobiological interests of this new department and will influence the future academic aims of the Department of Neuroscience and Institute of Psychiatry as a whole.

Type
Research Report
Information
Psychological Medicine , Volume 22 , Issue 1 , February 1992 , pp. 265 - 269
Copyright
Copyright © Cambridge University Press 1992

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Referemces

Anderton, B. J. & Brion, J. P. (1991). Ultrastructural and biochemical basis of Alzheimer's disease. Reviews in Clinical Gerontology 1, 17–28.Google Scholar
Balasubramanian, M. K., Brammer, M. J. & Campbell, I. C. (1991). Receptors linked second messenger systems in the CNS Indian Journal of Neurology (in the press).Google Scholar
Beats, B. & Kerwin, R. W. (1990). Increased forskolin binding in the left parahippocampal gyrus and CAI region in post-mortem schizophrenic brain determined by quantitative autoradiography. Neuroscience Letter 118, 164–168.Google Scholar
Brion, J. P., Hanger, D. P., Bruce, M. T., Couck, A. M., Flament-Dourand, J. & Anderton, B. H. (1991). Tau in Alzheimer neurofibrillary tangles. Biochemical Journal 272, 127–133.CrossRefGoogle Scholar
Docherty, M. (1991). Novel neurotransmitter specific cell surface molecules. Biochemical Society Transactions 19, 87–91.Google Scholar
Hajimohammedreza, I. & Brammer, M. J. (1990). Membrane fluidity and Lipid peroxidation in Alzheimers Disease. Neuroscience Letters 112, 333–337.Google Scholar
Harrison, L., Cheetham, M. & Calvert, (1990). Characterisation of a cDNA clone representing part of MAPix; a growth related neurone specific microtubule associated protein. Journal of Cellular Biochemistry, Suppl. 14F, 28.CrossRefGoogle Scholar
Harrison, P. J., McLaughlin, D. & Kerwin, R. W. (1991). Decreased hippocampal expression of a glutamate receptor gene in schizophrenia. Lancet 337, 450–452.Google Scholar
Hsu, Y. P., Powell, J. F., Sims, K. B. & Breakefield, X. (1989). Molecular genetics of the monoamine oxidases. Journal of Neurochemistry 53, 12–18.Google Scholar
Kerwin, R. W., Patel, S. & Meldrum, B. S. (1990). Receptor autoradiographic characterisation of glutamate receptors in human and schizophrenic hippocampus. Neuroscience 39, 25–32.Google Scholar
Marchbanks, R. M., Arendt, T., Allen, Y., Sinden, J., Schugeus, M. M., Lantos, P. L. & Gray, J. A. (1988). Cholinergic rich brain transplants reverse alcohol induced memory deficits. Nature 332, 448–450.Google Scholar
Marchbanks, R. M., Arendt, T. J., Allen, Y., Gray, J. A., Lantos, P. L., Schungens, M. M. & Sinden, J. (1989). Cholinergic systems and memory in the rat: effects of chronic ethanol on embryonic basal forebrain projection systems. Neuroscience 33, 435–462.Google Scholar
Powell, J. F., Sims, K. O., de la Chapelle, A. A., Norro, R., Sankila, E. M., Hsu, Y. P., Rinehart, W. P., Corey, T. J., Ozelius, L., Bruns, G., Gusella, J. F., Murphy, D. L. & Breakfield, X. O. (1989). Monoamine oxidase deficiency in males with an X-Chromosome deletion. Neuron 2, 1069–1076.Google Scholar
Twist, E., Mitchell, S. N., Brazell, C., Stahl, S. M. & Campbell, I. C. (1990). 5HT2 receptor changes in rat cortex and platelets following ketanserin and clorgyline. Biochemical Pharmacology 39, 161–166.Google Scholar
Whatley, S. A. & Nimgaonker, V. L. (1990). A specific effect of antipsychotic drugs on protein synthesis in human lymphonuclear cells. Journal of Neurochemistry 54, 1934–1940.Google Scholar
Whatley, S. A. & Owen, J. (1990). Molecular genetics and its application to the study of psychiatric disorders. International Reviews of Psychiatry 1, 219–330.Google Scholar
Whatley, S. A., Marchbanks, R. M., Perret, C. W. & Ferrier, I. N. (1990). An analysis of post-mortem gene expression in schizophrenic and control subjects. Schizophrenia Research 3, 15–18.Google Scholar
Xiang, J.-Z., Adamson, P., Brammer, M. J. & Campbell, I. C. (1990 a). The K-opiate antagonist U50488H decreases 4δC4 entry into rat cortical synaptosomes by inhibiting N- but not L-type calcium channels. Neuropharmacology 29, 437–444.CrossRefGoogle Scholar
Xiang, J.-Z., Morton, J., Brammer, M. J. & Campbell, J. C. (1990 b). Regulation of calcium concentrations in synaptosomes: α2 adrenoceptors reduce free calcium by closure of N-type calcium channels. Journal of Neurochemistry 55, 303–310.CrossRefGoogle Scholar